Marvel Financial Statements From 2010 to 2024
| MRVL Stock | 0.17 0.01 6.25% |
Check Marvel Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marvel Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Marvel financial statements analysis is a perfect complement when working with Marvel Biosciences Valuation or Volatility modules.
Marvel |
Marvel Biosciences Corp Company Return On Asset Analysis
Marvel Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Marvel Biosciences Return On Asset | -1.54 |
Most of Marvel Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Marvel Biosciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Marvel Biosciences Corp has a Return On Asset of -1.5364. This is 82.44% lower than that of the Biotechnology sector and 93.49% lower than that of the Health Care industry. The return on asset for all Canada stocks is notably higher than that of the company.
Marvel Biosciences Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Marvel Biosciences's current stock value. Our valuation model uses many indicators to compare Marvel Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marvel Biosciences competition to find correlations between indicators driving Marvel Biosciences's intrinsic value. More Info.Marvel Biosciences Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marvel Biosciences' earnings, one of the primary drivers of an investment's value.About Marvel Biosciences Financial Statements
Marvel Biosciences investors use historical fundamental indicators, such as Marvel Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Marvel Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.